Tag: Khiron Life Sciences

Cannabis Stocks Retreat in May

After a 57.4% rebound in Q1 followed by a narrow decline in April, Cannabis stocks, as measured by the Global Cannabis Stock Index, gave up substantial ground in May, declining...
- June 3rd, 2019 at 8:39 am

Khiron to Raise $25 Million Selling Shares at $2.90

Khiron Life Sciences Enters into $25 Million Bought Deal Equity Financing TORONTO, May 6, 2019 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF),...
- May 6th, 2019 at 5:37 pm

Khiron Raising $20 Million Selling Shares at $2.20

Khiron Life Sciences Enters Into $20 Million Bought Deal Equity Financing VANCOUVER, Feb. 6, 2019 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF),...
- February 6th, 2019 at 8:16 am

Cannabis Mutual Fund Makes Quarterly ETF Adjustments

Horizons ETFs Completes Rebalances of its Marijuana-focused ETFs TORONTO, Sept. 26, 2018 /CNW/ – Horizons ETFs Management (Canada) Inc. (“Horizons ETFs”) has completed the quarterly rebalance of the constituent holdings of...
- September 26th, 2018 at 8:14 am

Khiron to Raise Capital

Khiron Announces Filing of Marketed Short Form Prospectus Offering of Common Shares TORONTO, Aug. 21, 2018 (GLOBE NEWSWIRE) — Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN,...
- August 21st, 2018 at 4:36 pm

Khiron Lists on OTCQB Venture Market

TORONTO, Aug. 15, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQB: KHRNF), a Canadian integrated medical cannabis company with its core operations in...
- August 15th, 2018 at 5:54 pm

Khiron CBD Products Gain Colombian Regulatory Approval

Khiron Receives INVIMA Approval to Commercialize CBD Products for Colombian Domestic Sale and Export First Fully Licensed Company in Colombia to Receive INVIMA Approval TORONTO, May 30, 2018 /CNW/ – Khiron life Sciences...
- May 30th, 2018 at 8:27 am